GULF RESOURCES, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GULF RESOURCES, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $7.66M | Apr 11, 2025 |
| FY2024 | Dec 31, 2023 | $30.04M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $66.09M | Sep 27, 2024 |
| FY2022 | Dec 31, 2021 | $55.03M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $28.21M | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | $10.60M | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | $2.59M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $107.52M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $149.28M | Nov 9, 2018 |
| FY2016 | Dec 31, 2015 | $162.32M | Mar 17, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($58.94M) | Apr 11, 2025 |
| FY2024 | Dec 31, 2023 | ($61.80M) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $10.06M | Sep 27, 2024 |
| FY2022 | Dec 31, 2021 | ($924.7K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($8.42M) | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | ($25.80M) | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | ($69.96M) | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $7.95M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $36.23M | Nov 9, 2018 |
| FY2016 | Dec 31, 2015 | $34.07M | Mar 17, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($21.28M) | Apr 11, 2025 |
| FY2024 | Dec 31, 2023 | ($11.89M) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $16.48M | Sep 27, 2024 |
| FY2022 | Dec 31, 2021 | $5.21M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($9.68M) | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | ($23.29M) | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | ($83.55M) | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $11.17M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $47.72M | Nov 9, 2018 |
| FY2016 | Dec 31, 2015 | $45.16M | Mar 17, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $0 | Mar 15, 2019 |
| FY2018 | Dec 31, 2017 | $195.2K | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $261.9K | Nov 9, 2018 |
| FY2016 | Dec 31, 2015 | $230.6K | Mar 17, 2017 |
| FY2015 | Dec 31, 2014 | $134.3K | Mar 15, 2016 |
| FY2014 | Dec 31, 2013 | $140.4K | Mar 13, 2015 |
| FY2013 | Dec 31, 2012 | $164.6K | Mar 17, 2014 |
| FY2012 | Dec 31, 2011 | $398.8K | Mar 18, 2013 |
| FY2011 | Dec 31, 2010 | $2.20M | Mar 15, 2012 |
| FY2011 | Dec 31, 2009 | $500.4K | Mar 15, 2012 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $66.1K | Mar 15, 2019 |
| FY2018 | Dec 31, 2017 | $278.6K | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $343.1K | Nov 9, 2018 |
| FY2016 | Dec 31, 2015 | $375.4K | Mar 17, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $675.1K | Apr 11, 2025 |
| FY2024 | Dec 31, 2023 | ($32.75M) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $51.15M | Sep 27, 2024 |
| FY2022 | Dec 31, 2021 | $23.31M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $9.31M | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | ($15.31M) | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | $17.34M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $62.75M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $55.22M | Nov 9, 2018 |
| FY2016 | Dec 31, 2015 | $70.40M | Mar 17, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $60.53M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $37.56M | Sep 27, 2024 |
| FY2022 | Dec 31, 2021 | $30.09M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $21.72M | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | $60.61M | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | $35.27M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $17.94M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $17.00M | Nov 9, 2018 |
| FY2016 | Dec 31, 2015 | $22.86M | Mar 17, 2017 |
| FY2015 | Dec 31, 2014 | $6.54M | Mar 15, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $169.46M | Apr 11, 2025 |
| FY2024 | Dec 31, 2023 | $226.67M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $292.43M | Sep 27, 2024 |
| FY2022 | Dec 31, 2021 | $309.86M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $294.04M | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | $279.25M | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | $298.55M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $387.50M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $365.69M | Nov 9, 2018 |
| FY2016 | Dec 31, 2015 | $356.74M | Mar 17, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $25.75M | Apr 11, 2025 |
| FY2024 | Dec 31, 2023 | $21.42M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | $20.81M | Sep 27, 2024 |
| FY2022 | Dec 31, 2021 | $23.22M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $17.01M | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | $16.14M | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | $4.69M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $5.54M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $16.23M | Nov 9, 2018 |
| FY2016 | Dec 31, 2015 | $18.63M | Mar 17, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $143.71M | Apr 11, 2025 |
| FY2024 | Dec 31, 2023 | $205.25M | Apr 11, 2025 |
| FY2024 | Dec 31, 2022 | $271.62M | Apr 11, 2025 |
| FY2023 | Dec 31, 2021 | $286.64M | Sep 27, 2024 |
| FY2022 | Dec 31, 2020 | $277.02M | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $263.11M | Apr 12, 2022 |
| FY2020 | Dec 31, 2018 | $293.85M | Apr 8, 2021 |
| FY2019 | Dec 31, 2017 | $381.96M | Apr 14, 2020 |
| FY2018 | Dec 31, 2016 | $349.46M | Mar 15, 2019 |
| FY2017 | Dec 31, 2015 | $338.11M | Nov 9, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $0 | Mar 15, 2019 |
| FY2018 | Dec 31, 2017 | $29.37M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $27.67M | Nov 9, 2018 |
| FY2016 | Dec 31, 2015 | $29.56M | Mar 17, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $197.04M | Mar 18, 2013 |
| FY2012 | Dec 31, 2011 | $180.94M | Mar 18, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | (5) | Apr 11, 2025 |
| FY2024 | Dec 31, 2023 | (5) | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | 1 | Sep 27, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
| FY2018 | Dec 31, 2018 | (1) | Mar 15, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Nov 9, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Mar 17, 2017 |
| FY2015 | Dec 31, 2014 | 0 | Mar 15, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Mar 13, 2015 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | (1) | Mar 15, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Nov 9, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Mar 17, 2017 |
| FY2015 | Dec 31, 2014 | 0 | Mar 15, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Mar 13, 2015 |
| FY2013 | Dec 31, 2012 | 0 | Mar 17, 2014 |
| FY2012 | Dec 31, 2011 | 0 | Mar 18, 2013 |
| FY2011 | Dec 31, 2010 | 1 | Mar 15, 2012 |
| FY2011 | Dec 31, 2009 | 1 | Mar 15, 2012 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 10.73M | Apr 11, 2025 |
| FY2024 | Dec 31, 2023 | 10.73M | Apr 11, 2025 |
| FY2023 | Dec 31, 2022 | 10.43M | Sep 27, 2024 |
| FY2022 | Dec 31, 2021 | 10.47M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 10.00M | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | 9.52M | Apr 8, 2021 |
| FY2019 | Dec 31, 2018 | 9.36M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | 46.80M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | 46.79M | Nov 9, 2018 |
| FY2016 | Dec 31, 2015 | 46.01M | Mar 17, 2017 |